Johnson Kevin C 4
4 · NEOGENOMICS INC · Filed Dec 23, 2021
Insider Transaction Report
Form 4
Johnson Kevin C
Director
Transactions
- Exercise/Conversion
Common Stock
2021-12-22$7.27/sh+3,334$24,238→ 37,398 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-12-22−3,334→ 0 totalExercise: $7.27Exp: 2022-05-25→ Common Stock (3,334 underlying)
Holdings
- 4,269
Stock Options (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying) - 3,714
Stock Options (Right to Buy)
Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying) - 3,448
Stock Options (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying)
Footnotes (1)
- [F1]On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.